# What does research show about Semaglutide for postoperative outcomes in aging patients?

Canonical source: https://retacompare.com/research/what-does-research-show-about-semaglutide-for-postoperative-outcomes-in-aging-patients

Peptide Longevity Q&A · 2026-04-03


    Research indicates that preoperative Semaglutide use is generally associated with lower postoperative complications, including reduced infection rates and shorter hospital stays, particularly in orthopedic surgeries. This suggests potential benefits for aging patients undergoing such procedures.

What the research shows

The study reviewed the effects of preoperative glucagon-like peptide-1 receptor agonist (GLP-1 RA), specifically Semaglutide, on postoperative outcomes in orthopedic surgeries. The authors conducted a scoping review of 35 studies that included adult orthopedic patients who had documented GLP-1 RA use. The review focused on various surgical procedures such as hip, knee, and shoulder arthroplasties, spine fusions, trauma fixations, and soft-tissue sports medicine procedures. The outcomes measured included complications within 90 days post-surgery, rates of periprosthetic joint infections, length of hospital stays, readmission rates, and revisions. The findings suggest that Semaglutide use is linked to similar or lower complication rates across many procedures.

Why it matters for longevity

The implications of these findings are significant for longevity and healthspan, particularly among older adults who are often at higher risk for surgical complications. The association of Semaglutide with reduced postoperative infections and shorter hospital stays could contribute to improved recovery outcomes, potentially enhancing the quality of life for aging patients. Furthermore, minimizing complications can lead to better long-term health outcomes, which is crucial for maintaining independence and functional ability in older populations. As aging is often accompanied by increased surgical interventions, understanding the role of Semaglutide in this context may help inform preoperative care strategies for older adults.

Key findings at a glance

Preoperative Semaglutide use is linked to lower 90-day postoperative complications.

Reduced periprosthetic joint infections were observed in patients receiving Semaglutide.

Patients experienced shorter lengths of hospital stay post-surgery.

In some cases, there were fewer readmissions and revisions after surgery.

Spine surgery outcomes showed mixed results, indicating a need for cautious interpretation.

Soft-tissue procedures demonstrated fewer adverse events without increased risk of aspiration or revision.

How Semaglutide works (background)

Semaglutide is a GLP-1 receptor agonist that mimics the action of the incretin hormone GLP-1, which plays a role in glucose metabolism and appetite regulation. By activating GLP-1 receptors, Semaglutide promotes insulin secretion in response to meals, slows gastric emptying, and reduces appetite. These mechanisms can lead to weight loss and improved metabolic profiles, which are particularly beneficial for individuals with obesity and type 2 diabetes. In the context of surgical outcomes, these metabolic improvements may translate into lower risks of complications, as evidenced by the findings in orthopedic surgery.

Safety, caveats, and what we don't yet know

While the findings suggest potential benefits of Semaglutide in the perioperative setting, it is essential to note that the research is primarily observational and does not establish causality. Additionally, the mixed results observed in spine surgery cohorts indicate that further investigation is required to understand the implications of prolonged Semaglutide use. There is also a need for more prospective multicenter studies with standardized protocols and validated outcome measures, such as PROMIS, to better assess the long-term effects of Semaglutide on postoperative recovery and overall health in diverse populations.

Bottom line

Preoperative Semaglutide use appears to be associated with lower postoperative complications and improved recovery outcomes in orthopedic surgeries, particularly beneficial for aging patients.

Related questions

Can Semaglutide improve recovery times in older adults after surgery?

Research suggests that Semaglutide may shorten hospital stays and reduce complications, potentially leading to faster recovery times in older adults undergoing surgical procedures.

Does Semaglutide have any impact on postoperative infection rates?

Yes, studies indicate that preoperative Semaglutide use is associated with reduced rates of periprosthetic joint infections in orthopedic surgery patients.

What are the long-term effects of Semaglutide on aging populations?

While immediate postoperative benefits have been observed, further research is needed to evaluate the long-term effects of Semaglutide on healthspan and functional outcomes in aging populations.

Source: PubMed · J Am Acad Orthop Surg · published 2026-04-03.

## Sources

- PubMed · J Am Acad Orthop Surg: https://pubmed.ncbi.nlm.nih.gov/41930687/